NO983197L - Nye trisykliske forbindelser og medikamentsammensetninger inneholdende slike - Google Patents
Nye trisykliske forbindelser og medikamentsammensetninger inneholdende slikeInfo
- Publication number
- NO983197L NO983197L NO983197A NO983197A NO983197L NO 983197 L NO983197 L NO 983197L NO 983197 A NO983197 A NO 983197A NO 983197 A NO983197 A NO 983197A NO 983197 L NO983197 L NO 983197L
- Authority
- NO
- Norway
- Prior art keywords
- represents hydrogen
- amino
- compositions containing
- tricyclic compounds
- drug compositions
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/91—Dibenzofurans; Hydrogenated dibenzofurans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C307/00—Amides of sulfuric acids, i.e. compounds having singly-bound oxygen atoms of sulfate groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C307/04—Diamides of sulfuric acids
- C07C307/10—Diamides of sulfuric acids having nitrogen atoms of the sulfamide groups bound to carbon atoms of six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
- C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C311/08—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/30—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/37—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/80—[b, c]- or [b, d]-condensed
- C07D209/82—Carbazoles; Hydrogenated carbazoles
- C07D209/88—Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/76—Dibenzothiophenes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2603/00—Systems containing at least three condensed rings
- C07C2603/02—Ortho- or ortho- and peri-condensed systems
- C07C2603/04—Ortho- or ortho- and peri-condensed systems containing three rings
- C07C2603/06—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members
- C07C2603/10—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings
- C07C2603/12—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings only one five-membered ring
- C07C2603/18—Fluorenes; Hydrogenated fluorenes
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Diabetes (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Child & Adolescent Psychology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Indole Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Furan Compounds (AREA)
- Saccharide Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP257696 | 1996-01-10 | ||
PCT/JP1996/003689 WO1997025311A1 (fr) | 1996-01-10 | 1996-12-18 | Nouveaux composes tricycliques et compositions medicamenteuses contenant ces composes |
Publications (2)
Publication Number | Publication Date |
---|---|
NO983197L true NO983197L (no) | 1998-09-10 |
NO312159B1 NO312159B1 (no) | 2002-04-02 |
Family
ID=11533209
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO19983197A NO312159B1 (no) | 1996-01-10 | 1998-07-10 | Nye trisykliske forbindelser og medikamentsammensetninger inneholdende slike |
NO20012876A NO20012876D0 (no) | 1996-01-10 | 2001-06-11 | Nye trisykliske forbindelser og medikamentsammensetninger inneholdende slike |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20012876A NO20012876D0 (no) | 1996-01-10 | 2001-06-11 | Nye trisykliske forbindelser og medikamentsammensetninger inneholdende slike |
Country Status (14)
Country | Link |
---|---|
US (4) | US6037362A (no) |
EP (1) | EP0882707B1 (no) |
JP (1) | JP2000239255A (no) |
KR (1) | KR100395280B1 (no) |
CN (2) | CN1083831C (no) |
AT (1) | ATE251608T1 (no) |
AU (1) | AU715233B2 (no) |
CA (1) | CA2242351C (no) |
DE (1) | DE69630319T2 (no) |
ES (1) | ES2208772T3 (no) |
HK (1) | HK1017669A1 (no) |
NO (2) | NO312159B1 (no) |
PT (1) | PT882707E (no) |
WO (1) | WO1997025311A1 (no) |
Families Citing this family (48)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6025355A (en) * | 1997-05-19 | 2000-02-15 | Cambridge Neuroscience, Inc. | Pharmaceutically active compounds and methods of use |
DK0938467T3 (da) * | 1996-11-11 | 2002-10-07 | Sepracor Inc | Fremgangsmåde til fremstilling af optisk rene isomerer af formoterol |
US6040344A (en) * | 1996-11-11 | 2000-03-21 | Sepracor Inc. | Formoterol process |
CA2296104A1 (en) * | 1997-07-03 | 1999-01-14 | Asahi Kasei Kogyo Kabushiki Kaisha | Novel tricyclic compounds having saturated rings and medicinal compositions containing the same |
WO1999051564A1 (en) * | 1998-04-06 | 1999-10-14 | Fujisawa Pharmaceutical Co., Ltd. | Propanolamine derivatives |
US20030073644A1 (en) * | 1998-11-11 | 2003-04-17 | Smithkline Beecham P.L.C. | Combinations comprising a beta-agonist and a further antidiabetic agent |
AU766928B2 (en) * | 1998-11-11 | 2003-10-23 | Smithkline Beecham Plc | Combinations comprising a beta-agonist and a further antidiabetic agent |
KR20010080761A (ko) * | 1998-12-15 | 2001-08-22 | 야마모토 카즈모토 | 신규한 복소환 화합물 및 이를 함유하는 의약 조성물 |
TW519537B (en) | 1999-03-26 | 2003-02-01 | Asahi Chemical Ind | Process for the preparation of tricylic amino-alcohol derivatives |
CA2365503A1 (en) * | 1999-04-01 | 2000-10-12 | Koki Matsubara | Method for the preparation of tricyclic amino alcohol derivatives through azides |
EP1195371A1 (en) * | 1999-07-09 | 2002-04-10 | Asahi Kasei Kabushiki Kaisha | Process for the preparation of tricyclic amino alcohol derivatives |
US6696573B1 (en) | 1999-09-03 | 2004-02-24 | Asahi Kasei Kabushiki Kaisha | Processes for the preparation of tricyclic amino alcohol derivatives |
US20030220329A1 (en) * | 1999-09-17 | 2003-11-27 | Duke University | Method of improving beta-adrenergic receptor function |
WO2001025198A1 (fr) * | 1999-10-04 | 2001-04-12 | Asahi Kasei Kabushiki Kaisha | Amelioration de la solubilite de derives d'alcools amines tricycliques |
WO2001044187A1 (fr) * | 1999-12-16 | 2001-06-21 | Asahi Kasei Kabushiki Kaisha | Nouveaux composes tricycliques substitues |
US20030018061A1 (en) * | 2000-01-28 | 2003-01-23 | Kohei Ogawa | Novel remedies with the use of beta 3 agonist |
AU2001252575A1 (en) * | 2000-04-28 | 2001-11-12 | Asahi Kasei Kabushiki Kaisha | Novel tricyclic compounds |
WO2001083453A1 (fr) * | 2000-04-28 | 2001-11-08 | Asahi Kasei Kabushiki Kaisha | Nouveaux composes tricycliques substitues |
AU5257401A (en) * | 2000-04-28 | 2001-11-12 | Asahi Chemical Ind | Novel bicyclic compounds |
GB0010757D0 (en) * | 2000-05-05 | 2000-06-28 | Astrazeneca Ab | Chemical compounds |
MXPA03005648A (es) * | 2000-12-22 | 2003-10-06 | Astrazeneca Ab | Derivados de carbazol y su uso, como ligandos de receptor del neuropeptido y5. |
JPWO2002074306A1 (ja) * | 2001-03-19 | 2004-07-08 | 旭化成ファーマ株式会社 | 脂肪肝治療薬 |
GB0121941D0 (en) * | 2001-09-11 | 2001-10-31 | Astrazeneca Ab | Chemical compounds |
KR100816527B1 (ko) * | 2001-09-12 | 2008-04-10 | 한국화학연구원 | 페닐테트라졸 유도체로 치환된 β-아미노알코올 화합물 |
DE60228990D1 (de) | 2001-10-25 | 2008-10-30 | Asahi Kasei Pharma Corp | Bicyclische verbindung |
AU2003209527A1 (en) * | 2002-02-27 | 2003-09-09 | Pfizer Products Inc. | Crystal forms of (r)-2-(2-(4-oxazol-4-yl-phenoxy)-ethylamino)-1-pyridin-3-yl-ethanol |
US6864268B2 (en) | 2002-02-27 | 2005-03-08 | Pfizer Inc. | β3 adrenergic receptor agonists |
WO2003072547A1 (en) | 2002-02-27 | 2003-09-04 | Pfizer Products Inc. | PROCESSES AND INTERMEDIATES USEFUL IN PREPARING β3-ADRENERGIC RECEPTOR AGONISTS |
EP1424079A1 (en) * | 2002-11-27 | 2004-06-02 | Boehringer Ingelheim International GmbH | Combination of a beta-3-receptor agonist and of a reuptake inhibitor of serotonin and/or norepinephrine |
BRPI0407386A (pt) | 2003-02-14 | 2006-02-07 | Kissei Pharmaceutical | Derivados de álcool de amino, composições farmacêuticas contendo os mesmos e uso destes |
EP1679304A4 (en) * | 2003-10-24 | 2006-11-15 | Kissei Pharmaceutical | AMINO ALCOHOL DERIVATIVE, MEDICAL COMPOSITION CONTAINING THEREOF AND ITS USE |
US7718822B2 (en) | 2007-08-28 | 2010-05-18 | Sepracor Inc. | Carbamate Stereoisomer |
US8501994B2 (en) | 2007-08-28 | 2013-08-06 | Sunovion Pharmaceuticals Inc. | Acetamide stereoisomer |
CA2740772A1 (en) | 2008-10-09 | 2010-04-15 | Asahi Kasei Pharma Corporation | Indazole compounds |
AU2009301797B2 (en) * | 2008-10-09 | 2012-03-01 | Asahi Kasei Pharma Corporation | Indazole derivative |
US20100222404A1 (en) * | 2008-11-04 | 2010-09-02 | Asahi Kasei Pharma Corporation | Indazole derivative dihydrochloride |
CA2775464A1 (en) * | 2009-09-30 | 2011-04-07 | Asahi Kasei Pharma Corporation | Indazole analog |
WO2012032546A2 (en) * | 2010-09-08 | 2012-03-15 | Cadila Healthcare Limited | Process for the preparation of salmeterol and its intermediates |
ES2394349B1 (es) | 2012-08-29 | 2013-11-04 | Fundación Centro Nacional De Investigaciones Cardiovasculares Carlos Iii | Uso de agonistas selectivos de receptores beta-3 adrenérgicos para el tratamiento de hipertensión pulmonar |
WO2014108449A1 (en) | 2013-01-08 | 2014-07-17 | Atrogi Ab | A screening method, a kit, a method of treatment and a compound for use in a method of treatment |
WO2015003146A1 (en) | 2013-07-03 | 2015-01-08 | Georgetown University | Boronic acid derivatives of resveratrol for activating deacetylase enzymes |
US11053255B2 (en) | 2015-06-22 | 2021-07-06 | Georgetown University | Synthesis of mahanine and related compounds |
GB201714740D0 (en) | 2017-09-13 | 2017-10-25 | Atrogi Ab | New compounds and uses |
GB201714734D0 (en) | 2017-09-13 | 2017-10-25 | Atrogi Ab | New compounds and uses |
GB201714736D0 (en) | 2017-09-13 | 2017-10-25 | Atrogi Ab | New compounds and uses |
GB201714745D0 (en) | 2017-09-13 | 2017-10-25 | Atrogi Ab | New compounds and uses |
GB202205895D0 (en) | 2022-04-22 | 2022-06-08 | Atrogi Ab | New medical uses |
CN115656390B (zh) * | 2022-12-08 | 2023-03-28 | 成都苑东生物制药股份有限公司 | 一种氨酚羟考酮缓释片的含量测定方法 |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL33573A (en) * | 1968-12-30 | 1973-10-25 | Richardson Merrell Inc | Bis-basic ethers and thioethers of fluorenone,fluorenol and fluorene |
GB1521089A (en) * | 1975-11-12 | 1978-08-09 | Valeas Srl | Aminoethanol derivatives |
FR2332010A1 (fr) * | 1975-11-18 | 1977-06-17 | Continental Pharma | Amino-alcool heterocyclique, son sel et son procede de preparation |
DK31578A (da) * | 1977-02-03 | 1978-08-04 | Allen & Hanburys Ltd | Fremgangsmaade til fremstilling af benzenderivater |
JPS5473751A (en) * | 1977-10-12 | 1979-06-13 | Yamanouchi Pharmaceut Co Ltd | Phenyl ethanolamine derivatives and their preparation |
CA1147342A (en) * | 1977-10-12 | 1983-05-31 | Kazuo Imai | Process of producing novel phenylethanolamine derivatives |
JPS5553262A (en) * | 1978-10-17 | 1980-04-18 | Yamanouchi Pharmaceut Co Ltd | Phenylethanolamine derivative |
EP0023385B1 (en) * | 1979-06-16 | 1982-12-15 | Beecham Group Plc | Ethanamine derivatives, their preparation and use in pharmaceutical compositions |
JPS5950671B2 (ja) * | 1982-08-26 | 1984-12-10 | 山之内製薬株式会社 | フェニルエタノ−ルアミン誘導体およびその製造法 |
GB8419797D0 (en) * | 1984-08-03 | 1984-09-05 | Beecham Group Plc | Compounds |
US5061727A (en) * | 1990-05-04 | 1991-10-29 | American Cyanamid Company | Substituted 5-(2-((2-aryl-2-hydroxyethyl)amino)propyl)-1,3-benzodioxoles |
PL312005A1 (en) * | 1993-06-14 | 1996-04-01 | Pfizer | Binary amines as antidiabetic and antiobesitic agents |
US5776983A (en) * | 1993-12-21 | 1998-07-07 | Bristol-Myers Squibb Company | Catecholamine surrogates useful as β3 agonists |
IL113410A (en) * | 1994-04-26 | 1999-11-30 | Merck & Co Inc | Substituted sulfonamides having an asymmetric center and pharmaceutical compositions containing them |
JPH08165276A (ja) * | 1994-12-14 | 1996-06-25 | Dainippon Pharmaceut Co Ltd | 2−アルキルアミノ−1−フェニルエタノール誘導体 |
-
1996
- 1996-12-18 AU AU11708/97A patent/AU715233B2/en not_active Ceased
- 1996-12-18 DE DE69630319T patent/DE69630319T2/de not_active Expired - Lifetime
- 1996-12-18 KR KR10-1998-0705300A patent/KR100395280B1/ko not_active IP Right Cessation
- 1996-12-18 WO PCT/JP1996/003689 patent/WO1997025311A1/ja active IP Right Grant
- 1996-12-18 CN CN96180079A patent/CN1083831C/zh not_active Expired - Fee Related
- 1996-12-18 CA CA002242351A patent/CA2242351C/en not_active Expired - Fee Related
- 1996-12-18 US US09/101,232 patent/US6037362A/en not_active Expired - Fee Related
- 1996-12-18 AT AT96942564T patent/ATE251608T1/de not_active IP Right Cessation
- 1996-12-18 ES ES96942564T patent/ES2208772T3/es not_active Expired - Lifetime
- 1996-12-18 PT PT96942564T patent/PT882707E/pt unknown
- 1996-12-18 EP EP96942564A patent/EP0882707B1/en not_active Expired - Lifetime
-
1998
- 1998-07-10 NO NO19983197A patent/NO312159B1/no not_active IP Right Cessation
-
1999
- 1999-07-05 HK HK99102818A patent/HK1017669A1/xx not_active IP Right Cessation
- 1999-12-28 US US09/472,937 patent/US6187809B1/en not_active Expired - Fee Related
-
2000
- 2000-02-23 JP JP2000045460A patent/JP2000239255A/ja not_active Withdrawn
- 2000-11-02 CN CN00131988A patent/CN1295064A/zh active Pending
- 2000-11-16 US US09/713,202 patent/US6545053B1/en not_active Expired - Fee Related
-
2001
- 2001-06-11 NO NO20012876A patent/NO20012876D0/no not_active Application Discontinuation
-
2002
- 2002-09-30 US US10/259,462 patent/US20030139475A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CN1083831C (zh) | 2002-05-01 |
PT882707E (pt) | 2004-02-27 |
ATE251608T1 (de) | 2003-10-15 |
HK1017669A1 (en) | 1999-11-26 |
DE69630319D1 (de) | 2003-11-13 |
CA2242351A1 (en) | 1997-07-17 |
KR19990077162A (ko) | 1999-10-25 |
AU1170897A (en) | 1997-08-01 |
ES2208772T3 (es) | 2004-06-16 |
NO20012876D0 (no) | 2001-06-11 |
AU715233B2 (en) | 2000-01-20 |
US20030139475A1 (en) | 2003-07-24 |
NO20012876L (no) | 1998-09-10 |
DE69630319T2 (de) | 2004-07-29 |
US6545053B1 (en) | 2003-04-08 |
KR100395280B1 (ko) | 2004-06-04 |
EP0882707B1 (en) | 2003-10-08 |
JP2000239255A (ja) | 2000-09-05 |
CN1295064A (zh) | 2001-05-16 |
CA2242351C (en) | 2003-03-11 |
EP0882707A1 (en) | 1998-12-09 |
CN1209119A (zh) | 1999-02-24 |
EP0882707A4 (en) | 2001-04-11 |
US6187809B1 (en) | 2001-02-13 |
NO312159B1 (no) | 2002-04-02 |
US6037362A (en) | 2000-03-14 |
WO1997025311A1 (fr) | 1997-07-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20012876D0 (no) | Nye trisykliske forbindelser og medikamentsammensetninger inneholdende slike | |
BR1100131A (pt) | ácidos hidroxâmicos substituìdos por arilsulfonamido | |
HUT42272A (en) | Insecticides containing derivatives of nitro-methilen and process for production of the derivatives of nitromethilen | |
ATE91684T1 (de) | 1,2-cyclohexylaminoarylamide zu verwendung als analgetika. | |
DK0418071T3 (da) | Nye N-aryl- og N-heteroarylamid- og urinstofderivater som inhibitorer for acyl-coenzym A: cholesterol-acyltransferase | |
NO20005714D0 (no) | Nye substituerte cykliske forbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdende dem | |
ATE356813T1 (de) | Anilidderivate, deren herstellung und verwendung | |
NO981415D0 (no) | Nye N-arylpiperidin-forbindelser, en fremgangsmåte ved fremstilling derav og farmasöytiske preparater inneholdende slike | |
DE69512273T2 (de) | Amide von mono-und dicarbonsäuren mit glycosaminen, mit selektiver wirkung auf den peripheren cannabinoiden rezeptor | |
DK1200347T3 (da) | Syntese af ZSM-5 og ZSM-11 | |
HU9400250D0 (en) | Quinoline-or quinazoine derivatives process fop producing them and pharmaceutical compositions containing them | |
AU5386194A (en) | Tricyclic condensed heterocyclic compounds, their production and use | |
MX9301240A (es) | Derivados heterociclicos de cetona, condensados, metodo para su produccion y composicion farmaceutica que los contiene. | |
NZ228065A (en) | 1,2,4-triazinediones and parasiticidal compositions; processes for preparation | |
NO894349L (no) | Tienopyridin-type mevalonolaktoner. | |
DK0712398T3 (da) | Benzopyraner og farmaceutiske præparater, der indeholder dem | |
PT95651A (pt) | Processo para a preparacao de derivados de benzo-ciclo-alquilamino-piridinaminas e de composicoes farmaceuticas que os contem | |
ATE399778T1 (de) | Glucopyranosid, verfahren zu deren isolierung, pharmazeutische zusammensetzung und verwendung davon | |
BR9814161A (pt) | Método de sìntese de pirrolamidas | |
HU9601701D0 (en) | Aromatic hydroxamic acid compounds, process for producing them and their use | |
BR9705662A (pt) | Piridinas substituìdas. | |
DK0638554T3 (da) | Fremgangsmåde til fremstilling af et N-phenyl-N-(4-piperidinyl)amidderivat | |
PT79561A (fr) | Procede de preparation de nouveaux derives de beta-<2-(halogenobenzyl)-phenoxy>-ethylamine | |
DK0765866T3 (da) | Fremstilling af optisk aktiv (S)-(-)- og (R)-(+)-deoxyspergualin og nye mellemprodukter derfor |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM1K | Lapsed by not paying the annual fees |
Free format text: LAPSED IN JUNE 2003 |